PTPI
Petros Pharmaceuticals, Inc.
Key Financials
Net Income
$1.9M
↑ 113.4%
Revenue
$5.1M
↓ 12.2%
Operating Income
$-4641350
↑ 73.7%
Gross Profit
$3.9M
↓ 7.0%
EPS (Diluted)
$-1.56
↑ 53.3%
Total Assets
$5.2M
↓ 51.4%
Total Liabilities
$2.3M
↓ 87.3%
Shareholders' Equity
$2.9M
↑ 138.4%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 8-K | 9/30/2026 | View on SEC |
| 10-Q | 8/13/2026 | View on SEC |
| 3 | 6/25/2026 | View on SEC |
| 8-K | 6/18/2026 | View on SEC |
| 4 | 6/8/2026 | View on SEC |
| 4 | 6/5/2026 | View on SEC |
| 4 | 6/5/2026 | View on SEC |
| 4 | 6/5/2026 | View on SEC |
| 8-K | 6/5/2026 | View on SEC |
| 10-Q | 5/13/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | PTPI |
| Company Name | Petros Pharmaceuticals, Inc. |
| CIK | 1815903 |
| Sector | Pharmaceutical Preparations |
| Industry | Emerging growth company |
| Exchange | OTC |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 973-242-0005 |